Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • 2024-05
  • 2024-06
  • 2024-07
  • 2024-08
  • 2024-09
  • 2024-10
  • br Materials and methods br Results and discussion br Confli

    2022-03-07


    Materials and methods
    Results and discussion
    Conflict of interest
    Introduction In the presence of continuous and excessive levels of nutrients, adipocytes become hypertrophic and release several pro-inflammatory adipocytokines such as interleukin-6 (IL-6), monocyte chemoattractant protein-1/C-C motif chemokine ligand 2 (MCP-1/CCL2, hereafter CCL2), and tumor necrosis factor-alpha (TNF-α). These chemoattractants enhance the infiltration of macrophages and other immune cells into the adipose tissue. Moreover, in obesity, a high-fat diet influences the gut microbiota to enhance the baseline inflammatory response. This increases the circulating levels of inflammasomes such as lipopolysaccharide (LPS) [1], and thus toll-like receptors (TLRs) are activated in several cells, particularly adipocytes and macrophages [2]. Therefore, these receptors that respond to nutritional components might modulate adipocyte-macrophage interactions and contribute to the whole body metabolic status [2], [3]. It is now well documented that ω-3 polyunsaturated fatty CH5138303 (ω-3 PUFA)–rich diets activate the G-protein coupled receptor 120 (GPR120), which inhibits TLR-mediated nuclear factor kappa B (NF-κB) activation. Through this TLR-NF-κB cascade, GPR120 activation eventually inhibits the pro-inflammatory activity in adipocytes [2]. However, although obesity is commonly associated with chronic low-grade inflammation [2], [3], GPR120 expression in adipose tissues is increased in obese subjects [4]. Therefore, the precise molecular mechanisms linking the nutritional sensing of GPR120 activation with inflammatory responses requires further clarification with respect to inflammatory responses in adipocytes. Ligand-bound GPR120 in adipocytes activates the Gαq/11 subunit of G proteins, which stimulates protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) [5]. Subsequently, the phosphatidylinositol 3-kinase (PI3K)-Akt pathway is activated. This cascade facilitates cellular glucose uptake [5]. However, recent studies demonstrated that PKC-β inactivation in adipocytes enhanced fatty acid oxidation through the upregulation of mitochondrial peroxisome proliferator-activated receptor C coactivator 1alpha (PGC1α) and uncoupling protein-2 [6], [7]. In addition, PKC-δ activity in pancreatic acinar cells produced pro-inflammatory effects by activating the NF-κB pathway [8]. Taken together, the observations suggest that GPR120 activation may have differential effects on pro-inflammatory adipocytokines through the PKC and NF-κB pathways.
    Materials and methods Please see the supplementary materials for the details of Materials and Methods.
    Results
    Discussion Obesity is associated with a systemic low-grade inflammatory milieu [2] including activated TLRs mediated by the high serum levels of LPS [1]. In the current study, we showed that agonizing GPR120 using GSK137647 abolished the LPS-induced phosphorylation of IκBα and the nuclear translocation of p65, which downregulated the transcriptional factors, IL-6 and CCL2 CH5138303 (Fig. 1). This observation is in agreement with the transcriptional property of p65 on inflammatory cytokines [11]. Of note, docosahexaenoic acid (DHA), a ω-3 PUFA reduced the TNFα induced phosphorylation of IKKβ in 3T3-L1 adipocytes [5], whereas GSK137647 had no effect through IKKβ (Fig. 1C and D). We assume that a non-GPR120 (i.e. peroxisome proliferator-activated receptor gamma) mediated activity of DHA is responsible for the effect through IKKβ [12]. Moreover, GPR120 mediated signaling in adipocytes via the Gαq/11 subunit activates the PKC-PI3K-Akt pathway [5]. In our experimental model, we found that agonizing GPR120 using GSK137647 did not remarkably influence the phosphorylation of Erk or Akt (Fig. 1E). Therefore, our findings suggest that the anti-inflammatory activities of GPR120 activation only involve the NF-κB pathway (Fig. 1E–G), and that the contribution of the PI3K/Akt and Erk cascade is negligible. This selective antagonism of NF-κB was also reported for DHA-mediated GPR120 activation in hypothalamic neurons [13].